biosensis fine bioscience tools - antibodies, elisa kits, proteins, toxins and peptides An Australia-US partnershipPhone: 1800 605 5127 in the US, or +61 8 8352 7711 for international enquiries to Australia.
HomeAbout BiosensisBiosensis distributorsResourcesHelp deskordering from BiosensisContact usFlyers

Technical Notes
View our tech notes
Follow us...
Google+ Follow us on Twitter

Find us on Facebook

Sign up for Biosensis newsletters
Visit our newsletter archive
News and Site Information.

At the forefront of personalised diagnostics and therapeutics.

Biosensis joins a team of researchers to establish a new Australian Research Council (ARC) training center

Biosensis is part of the team of companies and research organizations that was awarded Australian Research Council funding in June 2017. In collaboration with researchers in Singapore and across Australia, we are establishing the ARC Training Center for Personalized Therapeutics Technologies. This new center aims to develop high-throughput, real-time technologies, based on micro-fluidic systems, to provide improved patient screening, which will ultimately enable truly personalized diagnostics and therapeutic decisions.

This center will be established from the $3.1 million ARC seed-funding, together with a further $10 million in cash and in-kind support from the partners (including Biosensis). This represents a significant step for Biosensis as we aim to remain at the forefront of medical research to ensure that you, our customers, have access to the best validated neuroscience reagents.